skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Repurposing existing drugs may provide new dementia treatments

Repurposing existing drugs may provide new dementia treatments

20 April 2017

Researchers from the MRC’s Toxicology Unit have identified two drugs that restore protein production rates in mice that have either prion disease or frontotemporal dementia (FTD), and which may therefore have potential as dementia treatments in humans. They are trazodone hydrochloride, a licensed antidepressant, and...


Read more at: Elysium Health joins Milner Therapeutics Consortium

Elysium Health joins Milner Therapeutics Consortium

29 March 2017

The Milner Therapeutics Institute has announced Elysium Health as the latest company to become a partner in the Milner Therapeutics Consortium, which brings together the drug development capabilities of pharmaceutical companies with the ideas and know-how of Cambridge academics. The company will also join the Institute's...


Read more at: £5 million gift from Cambridge alumnus to further dementia research

£5 million gift from Cambridge alumnus to further dementia research

27 March 2017

R. Derek Finlay, a former student of the University of Cambridge and long-standing donor to Collegiate Cambridge, is donating £5 million to help fund the completion of the new Chemistry of Health building at the Department of Chemistry, and to support research into neurodegenerative diseases. A plaque unveiled by Finlay...


Read more at: Cambridge Academy of Therapeutic Sciences opens for business

Cambridge Academy of Therapeutic Sciences opens for business

21 March 2017

On 9 March, Vice Chancellor Professor Sir Leszek Borysiewicz and Pro-Vice Chancellor for Research, Professor Chris Abell welcomed an audience of 150 pharmaceutical and biotech company leaders, industry and professional body representatives, and senior academics to hear about the mission and vision of the Cambridge Academy...


Read more at: A myriad of opportunities to explore therapeutic sciences at #CSF2017

A myriad of opportunities to explore therapeutic sciences at #CSF2017

13 March 2017

Cambridge Science Festival 2017 kicks off today and the enormous line-up of events looks fantastic as usual. If you’re anything like us, you would need to clone yourself to go to everything you’d like to see. To save you time scouring the whole programme of events, we have pulled together some highlights relevant to the...


Read more at: Cambridge amongst seven universities involved in new £100M multi-disciplinary Rosalind Franklin Institute

Cambridge amongst seven universities involved in new £100M multi-disciplinary Rosalind Franklin Institute

3 March 2017

Business Secretary Greg Clark has announced the creation of a new institute named in honour of Rosalind Franklin, whose pioneering use of X-rays to study biological structures played a key role in the discovery of DNA’s ‘double helix’ structure. The institute will have its hub at the Harwell campus near Oxford. It will...


Read more at: Industrial Strategy Challenge Fund engagement underway

Industrial Strategy Challenge Fund engagement underway

28 February 2017

Innovate UK and the Research Councils are seeking input from scientists and businesses over the roll out of a £4.7BN cross-disciplinary fund. This will support industry-led programmes of activity aiming to deliver economic impact, jobs and growth. Workshops have been taking place across the country with delegates from the...


Read more at: Milner Therapeutics Institute adds Pfizer to list of partners

Milner Therapeutics Institute adds Pfizer to list of partners

28 February 2017

In January, the Milner Institute announced that Pfizer are the latest partner to join the Milner Therapeutics Consortium, which brings together the drug development capabilities of leading pharmaceutical companies with the ideas and know-how of Cambridge academics. The other existing industrial partners are Astex...